Literature DB >> 27458289

Can Observational Data Replace Randomized Trials?

Paul McGale1, David Cutter1, Sarah C Darby1, Katherine E Henson1, Reshma Jagsi2, Carolyn W Taylor3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27458289     DOI： 10.1200/JCO.2016.68.8879

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

1.  Comparison of Population-Based Observational Studies With Randomized Trials in Oncology.

Authors:  Payal D Soni; Holly E Hartman; Robert T Dess; Ahmed Abugharib; Steven G Allen; Felix Y Feng; Anthony L Zietman; Reshma Jagsi; Matthew J Schipper; Daniel E Spratt
Journal:  J Clin Oncol       Date:  2019-03-21       Impact factor: 44.544

Review 2.  Individualization of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer : A systematic review.

Authors:  David Krug; René Baumann; Wilfried Budach; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; Thomas Hehr; Marc D Piroth; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2018-01-30       Impact factor: 3.621

3.  Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.

Authors:  Robert T Dess; Holly E Hartman; Brandon A Mahal; Payal D Soni; William C Jackson; Matthew R Cooperberg; Christopher L Amling; William J Aronson; Christopher J Kane; Martha K Terris; Zachary S Zumsteg; Santino Butler; Joseph R Osborne; Todd M Morgan; Rohit Mehra; Simpa S Salami; Amar U Kishan; Chenyang Wang; Edward M Schaeffer; Mack Roach; Thomas M Pisansky; William U Shipley; Stephen J Freedland; Howard M Sandler; Susan Halabi; Felix Y Feng; James J Dignam; Paul L Nguyen; Matthew J Schipper; Daniel E Spratt
Journal:  JAMA Oncol       Date:  2019-07-01       Impact factor: 31.777

4.  Making progress in early breast cancer: Taking time or accepting risk?

Authors:  Gurdeep S Mannu; David Dodwell
Journal:  Eur J Cancer       Date:  2017-04-12       Impact factor: 9.162

5.  Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases.

Authors:  Stefanie Corradini; Montserrat Pazos; Stephan Schönecker; Daniel Reitz; Maximilian Niyazi; Ute Ganswindt; Simone Schrodi; Michael Braun; Martin Pölcher; Sven Mahner; Nadia Harbeck; Jutta Engel; Claus Belka
Journal:  Radiat Oncol       Date:  2018-02-09       Impact factor: 3.481

6.  Infrastructure and distributed learning methodology for privacy-preserving multi-centric rapid learning health care: euroCAT.

Authors:  Timo M Deist; A Jochems; Johan van Soest; Georgi Nalbantov; Cary Oberije; Seán Walsh; Michael Eble; Paul Bulens; Philippe Coucke; Wim Dries; Andre Dekker; Philippe Lambin
Journal:  Clin Transl Radiat Oncol       Date:  2017-05-19

Review 7.  Harnessing data science to advance radiation oncology.

Authors:  Ivan R Vogelius; Jens Petersen; Søren M Bentzen
Journal:  Mol Oncol       Date:  2020-05-18       Impact factor: 6.603

8.  Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries.

Authors:  Katherine E Henson; Paul McGale; Sarah C Darby; Max Parkin; Yaochen Wang; Carolyn W Taylor
Journal:  Int J Cancer       Date:  2020-03-04       Impact factor: 7.396

Review 9.  Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.

Authors:  Amanda J Kerr; David Dodwell; Paul McGale; Francesca Holt; Fran Duane; Gurdeep Mannu; Sarah C Darby; Carolyn W Taylor
Journal:  Cancer Treat Rev       Date:  2022-03-04       Impact factor: 13.608

10.  Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making.

Authors:  Robbe Saesen; Stéphane Lejeune; Gianluca Quaglio; Denis Lacombe; Isabelle Huys
Journal:  Front Pharmacol       Date:  2020-02-05       Impact factor: 5.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.